Globus Medical announced its US$ 250 million acquisition of Nevro on February 6, 2025, gaining control of 800+ spinal cord stimulation (SCS) patents. This acquisition expands Globus' neuromodulation patent portfolio and strengthens its position in the US$13.3 billion spinal device market. Market that is forecast to grow